Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 3981790, 9 pages
http://dx.doi.org/10.1155/2016/3981790
Research Article

Central Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats

1Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University, Shenyang 110004, China
2Department of Pathophysiology, Hebei North University, Zhangjiakou, Hebei 075000, China
3Life Science Research Center, Hebei North University, Zhangjiakou, Hebei 075000, China

Received 7 August 2015; Revised 11 September 2015; Accepted 13 September 2015

Academic Editor: Hanjun Wang

Copyright © 2016 Shu-Yan Dai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. M. Steckelings, L. Paulis, P. Namsolleck, and T. Unger, “AT2 receptor agonists: hypertension and beyond,” Current Opinion in Nephrology and Hypertension, vol. 21, no. 2, pp. 142–146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Sumners, A. D. de Kloet, E. G. Krause, T. Unger, and U. M. Steckelings, “Angiotensin type 2 receptors: blood pressure regulation and end organ damage,” Current Opinion in Pharmacology, vol. 21, pp. 115–121, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. L. C. Matavelli and H. M. Siragy, “AT2 receptor activities and pathophysiological implications,” Journal of Cardiovascular Pharmacology, vol. 65, pp. 226–232, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Gao and I. H. Zucker, “AT2 receptor signaling and sympathetic regulation,” Current Opinion in Pharmacology, vol. 11, no. 2, pp. 124–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Gao, J. Chao, K.-J. K. Parbhu et al., “Ontogeny of angiotensin type 2 and type 1 receptor expression in mice,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 13, no. 3, pp. 341–352, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. de Kloet, L. Wang, J. A. Ludin et al., “Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system,” Brain Structure and Function, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Abdulla and E. J. Johns, “Nitric oxide impacts on angiotensin AT2 receptor modulation of high-pressure baroreflex control of renal sympathetic nerve activity in anaesthetized rats,” Acta Physiologica, vol. 210, no. 4, pp. 832–844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Gao, W. Wang, W. Wang, H. Li, C. Sumners, and I. H. Zucker, “Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats,” Hypertension, vol. 51, no. 2, pp. 521–527, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Gao, I. H. Zucker, and L. Gao, “Activation of central Angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure,” American Journal of Hypertension, vol. 27, no. 10, pp. 1248–1256, 2014. View at Publisher · View at Google Scholar
  10. S. Brouwers, I. Smolders, R. Wainford, and A. Dupont, “Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats,” Clinical Science, vol. 129, no. 1, pp. 81–92, 2015. View at Publisher · View at Google Scholar
  11. K. M. Denton, L. M. Hilliard, and M. Tare, “Sex-related differences in hypertension: seek and ye shall find,” Hypertension, vol. 62, no. 4, pp. 674–677, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. I. Rodriguez-Perez, R. Valenzuela, B. Villar-Cheda, M. J. Guerra, J. L. Lanciego, and J. L. Labandeira-Garcia, “Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease,” Experimental Neurology, vol. 224, no. 2, pp. 517–526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. I. Rodriguez-Perez, R. Valenzuela, B. Villar-Cheda, M. J. Guerra, and J. L. Labandeira-Garcia, “Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system,” Brain, vol. 135, no. 1, pp. 124–138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. R. Kisley, R. R. Sakai, and S. J. Fluharty, “Estrogen decreases hypothalamic angiotensin II AT1 receptor binding and mRNA in the female rat,” Brain Research, vol. 844, no. 1-2, pp. 34–42, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. A. K. Sampson, L. M. Hilliard, K. M. Moritz et al., “The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 302, no. 1, pp. R159–R165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. K. M. Mirabito, L. M. Hilliard, Z. Wei et al., “Role of inflammation and the angiotensin type 2 receptor in the regulation of arterial pressure during pregnancy in mice,” Hypertension, vol. 64, no. 3, pp. 626–631, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. McCarthy, R. E. Widdop, K. M. Denton, and E. S. Jones, “Update on the angiotensin AT2 receptor,” Current Hypertension Reports, vol. 15, no. 1, pp. 25–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. Ali, Y. Wu, and T. Hussain, “Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats,” Kidney International, vol. 84, no. 5, pp. 931–939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Dhande, Q. Ali, and T. Hussain, “Proximal tubule angiotensin AT2 receptors mediate an anti-inflammatory response via interleukin-10: role in renoprotection in obese rats,” Hypertension, vol. 61, no. 6, pp. 1218–1226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Sabuhi, Q. Ali, M. Asghar, N. R. H. Al-Zamily, and T. Hussain, “Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats,” American Journal of Physiology—Renal Physiology, vol. 300, no. 3, pp. F700–F706, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Dhande, W. Ma, and T. Hussain, “Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production,” Hypertension Research, vol. 38, no. 1, pp. 21–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Menk, J. A. Graw, C. von Haefen et al., “Stimulation of the angiotensin II AT2 receptor is anti-inflammatory in human lipopolysaccharide-activated monocytic cells,” Inflammation, vol. 38, no. 4, pp. 1690–1699, 2015. View at Publisher · View at Google Scholar
  23. Q. Ali, S. Patel, and T. Hussain, “Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats,” The American Journal of Physiology—Renal Physiology, vol. 308, no. 12, pp. F1379–F1385, 2015. View at Publisher · View at Google Scholar
  24. S. Y. Dai, W. Peng, Y. P. Zhang, J. D. Li, Y. Shen, and X. F. Sun, “Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats,” Journal of Neuroinflammation, vol. 12, article 47, 2015. View at Publisher · View at Google Scholar
  25. H. Zheng, N. M. Sharma, X. Liu, and K. P. Patel, “Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 303, no. 4, pp. R387–R394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Hilliard, C. L. E. Chow, K. M. Mirabito et al., “Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats,” Hypertension, vol. 64, no. 2, pp. 378–383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. B. A. Kemp, N. L. Howell, J. J. Gildea, S. R. Keller, S. H. Padia, and R. M. Carey, “AT2 receptor activation induces natriuresis and lowers blood pressure,” Circulation Research, vol. 115, no. 3, pp. 388–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Xu, S. Sriramula, and E. Lazartigues, “ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good,” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, vol. 300, no. 4, pp. R804–R817, 2011. View at Publisher · View at Google Scholar
  29. X.-A. Song, L.-L. Jia, W. Cui et al., “Inhibition of TNF-α in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by inhibiting neurohormonal excitation in spontaneously hypertensive rats,” Toxicology and Applied Pharmacology, vol. 281, no. 1, pp. 101–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Sriramula, J. P. Cardinale, and J. Francis, “Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension,” PLoS ONE, vol. 8, no. 5, Article ID e63847, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. J. Winklewski, M. Radkowski, M. Wszedybyl-Winklewska, and U. Demkow, “Brain inflammation and hypertension: the chicken or the egg?” Journal of Neuroinflammation, vol. 12, article 85, 2015. View at Publisher · View at Google Scholar
  32. L. M. Hilliard, A. K. Sampson, R. D. Brown, and K. M. Denton, “The ‘His and Hers’ of the renin-angiotensin system,” Current Hypertension Reports, vol. 15, no. 1, pp. 71–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Xue, D. Badaue-Passos Jr., F. Guo, C. E. Gomez-Sanchez, M. Hay, and A. K. Johnson, “Sex differences and central protective effect of 17β-estradiol in the development of aldosterone/NaCl-induced hypertension,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1577–H1585, 2009. View at Publisher · View at Google Scholar · View at Scopus